BiosimilarDrug
MB02 clinical trials
A product of Bevacizumab; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 1
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
- MB02
- 1
Studies by the year they started
4 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses MB02 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male VolunteersCompletedPhase 1mAbxience Research S.L.NCT04238663Written as MB02 (Bevacizumab Biosimilar)
- A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)CompletedPhase 3mAbxience Research S.L.NCT03296163Written as MB02 (Bevacizumab Biosimilar Drug)
- A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male VolunteersCompletedPhase 1mAbxience Research S.L.NCT04238650Written as MB02 (Bevacizumab Biosimilar)
- A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male VolunteersCompletedPhase 1mAbxience Research S.L.NCT03293654Written as MB02